Market revenue in 2023 | USD 474.1 million |
Market revenue in 2030 | USD 662.5 million |
Growth rate | 4.9% (CAGR from 2023 to 2030) |
Largest segment | Equipment |
Fastest growing segment | Disposables |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Equipment, Disposables |
Key market players worldwide | Agilent Technologies Inc, Bio-Rad Laboratories Inc, Bruker Corp, Danaher Corp, FUJIFILM Holdings Corp, PerkinElmer, Sartorius AG, Shimadzu Corp, Thermo Fisher Scientific Inc, Waters Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to laboratory supplies market will help companies and investors design strategic landscapes.
Equipment was the largest segment with a revenue share of 64.08% in 2023. Horizon Databook has segmented the South Africa laboratory supplies market based on equipment, disposables covering the revenue growth of each sub-segment from 2018 to 2030.
Government initiatives such as development of special economic zones, Tripartite Free Trade Area, tax breaks, and establishment of South African Health Products Regulatory Authority (SAHPRA) are expected to increase the number of foreign investments & collaborations in South Africa, facilitating market growth.
Moreover, an increase in the number of public-private partnerships and a growing need for upgrading hospitals & laboratories are other factors expected to create opportunities for market players. As per the National Research and Experimental Development Survey, South Africa’s gross expenditure on R&D increased in 2017 & 2018 accounting for 0.82% of its GDP.
This indicates that R&D in the country is growing at a slow pace; however, concerns still remain as the expenditure is still relatively lower than other countries. In September 2019, iBio, Inc.—under an MOU—entered into its initial Statement of Work (SOW1) with South Africa’s Azar Gen Biotechnologies (Pty.) Ltd. Under SOW1, iBio would develop research quantities of plant-made rituximab using its proprietary Fast Pharming System for Azar Gen.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa laboratory supplies market , including forecasts for subscribers. This country databook contains high-level insights into South Africa laboratory supplies market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account